Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.26 USD | +1.61% | +12.51% | -61.11% |
May. 21 | Hepion Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 22 | Sector Update: Health Care Stocks Increase Late Afternoon | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 6.9M |
---|---|---|---|---|---|
Net income 2024 * | -51M | Net income 2025 * | -76M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.11
x | P/E ratio 2025 * |
-
| Employees | 22 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.69% |
1 day | +1.61% | ||
1 week | +12.51% | ||
1 month | -7.35% | ||
3 months | -60.25% | ||
6 months | -62.94% | ||
Current year | -61.11% |
Managers | Title | Age | Since |
---|---|---|---|
John Cavan
CEO | Chief Executive Officer | 65 | 15-12-31 |
Daren Ure
CTO | Chief Tech/Sci/R&D Officer | - | 19-10-02 |
Stephen Kilmer
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
John Brancaccio
CHM | Chairman | 76 | 13-05-14 |
Timothy Block
BRD | Director/Board Member | 69 | 13-11-25 |
Kaouthar Lbiati
BRD | Director/Board Member | 45 | 22-06-26 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 1.26 | +1.61% | 16,270 |
24-05-30 | 1.24 | +3.33% | 78,723 |
24-05-29 | 1.2 | +4.35% | 23,587 |
24-05-28 | 1.15 | +2.69% | 17,203 |
24-05-24 | 1.12 | -1.76% | 43,634 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-61.11% | 6.9M | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- HEPA Stock